This site is intended for healthcare professionals only
LoginRegister
Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human ResourcesStrides Pharma Science Singapore arm to acquire 100 percent stake in Amexel
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Labs recalls epilepsy drug in US over infusion bag mislabeling
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer Finerenone secures USFDA Priority Review designation for heart failure
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentAstraZeneca to acquire EsoBiotec for up to USD 1 billion
Dr Reddys, Zydus recall products in US over manufacturing issuesSun Pharma, Zydus recall products in US over manufacturing issues
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoeaUSFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoea
Lupin bags tentative USFDA nod for rare autoimmune disorder drug AmifampridineLupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine
AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancerAstraZeneca Imfinzi approved in EU for limited stage small cell lung cancer
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Laboratories gets CDSCO Panel nod to study Rabeprazole Sodium Modified Release Capsules
Novartis concludes acquisition of Tourmaline BioCDSCO Panel Approves Updated Package Insert for Novartis' Ofatumumab Injection
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales WarningNo Long-Term Safety Data: CDSCO Panel Denies Novo Nordisk's proposal to amend warning statement of...
DoP organises Industry dialogue on PRIP Scheme in MumbaiDoP organises Industry dialogue on PRIP Scheme in Mumbai
X